XML 21 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Changes in Shareholders' Equity (Deficiency) - USD ($)
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (loss) [Member]
Total
Balance at Dec. 31, 2016 $ 221 $ 8,873,110 $ (13,573,105) $ (4,699,774)
Balance, shares at Dec. 31, 2016 2,207,450          
Stock issued with respect to merger of Beyond Air $ 10 (295,000) (294,990)
Stock issued with respect to merger of Beyond Air shares 103,200          
Purchase of treasury stock $ (9) (25,000) (25,009)
Purchase of treasury stock, shares (90,000)          
Stock-based compensation - employees and non-employees 537,000 537,000
Stock-based compensation related to restricted stock issuance of shares to members of board of directors $ 86 2,521,000 2,521,086
Stock-based compensation related to restricted stock issuance of shares to members of board of directors, shares 856,909          
Cancellation of restricted stock granted to a member of the board of directors $ (25) 844,000 843,975
Cancellation of restricted stock granted to a member of the board of directors, shares (246,312)          
Issuance of warrants to service provider 480,000 480,000
Stock-based compensation related to restricted stock issuance of shares to members of board of directors $ 1 4,000 4,001
Stock-based compensation related to restricted stock issuance of shares to members of board of directors, shares 3,927          
Issuance of common stock, net of issuance costs $ 181 6,322,000 6,322,181
Issuance of common stock, net of issuance costs, shares 1,812,110          
Conversion of convertible notes into common stock upon merger $ 140 3,973,000 3,973,140
Conversion of convertible notes into common stock upon merger, shares 1,397,068          
Issuance of stock upon exercise of stock options $ 5 1,000 1,005
Issuance of stock upon exercise of stock options, shares 52,902          
Net unrealized gains (loss) on available-for-sale investments 2,149 2,149
Adjustment due to adoption of ASU 2016-01 (Note 2)          
Net (loss) income (18,044,346) (18,044,346)
Balance at Dec. 31, 2017 $ 610 (25,000) 23,260,110 (31,617,451) 2,149 (8,379,582)
Balance, shares at Dec. 31, 2017 6,097,254          
Stock-based compensation - employees and non-employees 130,000 130,000
Stock-based compensation related to restricted stock issuance of shares to members of board of directors 17,000 17,000
Issuance of common stock, net of issuance costs $ 230 8,734,000 8,734,230
Issuance of common stock, net of issuance costs, shares 2,299,802          
Net unrealized gains (loss) on available-for-sale investments (5,135) (5,135)
Adjustment due to adoption of ASU 2016-01 (Note 2)          
Net (loss) income 1,047,687 1,047,687
Balance at Mar. 31, 2018 $ 840 (25,000) 32,141,110 (30,569,764) (2,986) 1,544,200
Balance, shares at Mar. 31, 2018 8,397,056          
Adjustment due to the Adoption of ASU- 2017-11 6,194,292 [1] (516,358) [1] 5,677,934 [1]
At the market stock sales $ 29 799,156 799,185
At the market stock sales, shares 297,000          
Issuance of common stock upon the exercise of stock options $ 2 8,699 8,701
Issuance of common stock upon the exercise of stock options, shares 20,759          
Stock-based compensation 2,550,321 2,550,321
Adjustment due to adoption of ASU 2016-01 (Note 2) 2,986 (2,986)
Net (loss) income (6,558,450) (6,558,450)
Balance at Mar. 31, 2019 $ 871 $ (25,000) $ 41,693,578 $ (37,644,572) $ 0 $ 4,024,877
Balance, shares at Mar. 31, 2019 8,714,815          
[1] The Company elected to adopt Accounting Standards Update 2017-11 retrospective to outstanding financial instruments with down round feature by means of cumulative-effect adjustment to the beginning additional paid-in capital of $6,194,292 and accumulated deficit of $(516,358) as of April 1, 2018. This ASU affects all entities that issue financial instruments (for example, warrants or convertible instruments) that include down round features.